Delivery Order SPE2DX22D0010-SPE2D825FFB26

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.57, is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,787.26, is for the delivery of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The contract has a completion date of November 21, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,208.98 firm fixed price contract is for the delivery of XTAMPZA ER 13.5 MG capsules, a specialty medication product. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,344.17, is for the delivery of XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract is a delivery order with a firm fixed price and has an ultimate completion date of February 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,379.48, is a Delivery Order awarded under the DLA's Indefinite Delivery Contract (IDC) for providing XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. Amerisourcebergen holds a $999,999,999 IDC with DLA Troop Support Medical to supply a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,863.30 firm fixed-price delivery order is for the supply of XTAMPZA ER 36 MG capsules. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XTAMPZA ER CAPS 36MG. The contract has a ceiling value of $6,166.47 and an ultimate completion date of September 25, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite...
The U.S. government awarded a $2,862.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of XTAMPZA ER CAPS 36MG, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the primary vehicle...
This federal contract award, with ID SPE2DB24D2215|SPE2DB25FGSUR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,808.62 firm fixed-price delivery order is for the supply of 4,568,062,525 units of the prescription medication XTAMPZA ER 27 MG CAPSULE 100S. The contract has an ultimate completion date of April 29, 2025 and does not utilize any set-aside designations, indicating open...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FFB26
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XTAMPZA ER CAPS 27MG, a prescription medication, with a ceiling value of $1,980.78 and a period of performance ending on April 21, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs.

Generated 7/18/25, 10:02 AM